Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Pilot Study to Evaluate the Efficacy and Safety of Tadalafil and Tamsulosin Once-a-Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 22 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2009 Actual patient number (151) added as reported by ClinicalTrials.gov.
- 30 Oct 2007 New trial record.